Skip to content
ppharmaranks
Menu
Class IIOngoing

Lil Drug Store recall

FDA recall D-0632-2026 · initiated Jun 2, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Jun 24, 2026How we research

Dabur India Limited recalled Lil Drug Store in Jun 2026 — an FDA Class II recall (D-0632-2026) because CGMP Deviations; deficiencies observed during FDA inspection.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

CGMP Deviations; deficiencies observed during FDA inspection

The manufacturing process itself

The FDA found the process itself out of compliance, usually before any defective product was identified.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot# 0005, within expiry

Quantity recalled: 1225 tubes

Details

Product
Lil Drug Store, Triple Antibiotic Ointment, Bacitracin Zinc (400 units), Neomycin Sulfate (3.5 mg), Polymyxin-B Sulfate (5000 units), net wt. 0.5 oz (14.2g), Product distributed by: Lil' Drug Store Products, Inc., 9300 Earhart Lane SW, Cedar Rapids, IA 52404, Made in India, UPC 3 66715 97310 8.
Recalling company
Dabur India Limited
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
US Nationwide.
Initiated
Jun 2, 2026
FDA report date
Jun 24, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Lil Drug Store recalled?
Dabur India Limited recalled Lil Drug Store in Jun 2026 — an FDA Class II recall (D-0632-2026) because CGMP Deviations; deficiencies observed during FDA inspection. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Lil Drug Store recalled?
Per the FDA enforcement record, the reason for recall D-0632-2026 was: CGMP Deviations; deficiencies observed during FDA inspection
Is a recalled Lil Drug Store dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Lil Drug Store are affected?
Distributed: US Nationwide.. The recall covers these lots — Lot# 0005, within expiry. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0632-2026.

Source: openFDA Drug Enforcement record D-0632-2026

← All drug recalls